Â¥
15.24
Nov 12
New Key Statistics Module, Z-Score and F-Score
SZSE:301263 Key Ratios
Market Cap ¥ M | 6,484.58 |
Enterprise Value ¥ M | 5,987.18 |
P/E(ttm) | 47.63 |
PE Ratio without NRI | 42.81 |
Forward PE Ratio | -- |
Price/Book | 3.65 |
Price/Sales | 8.55 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 142.35 |
Payout Ratio % | 0.84 |
Revenue (TTM) ¥ M | 752.00 |
EPS (TTM) ¥ | 0.32 |
Beneish M-Score | -2.29 |
10-y EBITDA Growth Rate % | 8.00 |
5-y EBITDA Growth Rate % | 8.00 |
y-y EBITDA Growth Rate % | -30.20 |
EV-to-EBIT | 37.58 |
EV-to-EBITDA | 37.58 |
PEG | 5.35 |
Shares Outstanding M | 425.50 |
Net Margin (%) | 17.91 |
Operating Margin % | 22.63 |
Pre-tax Margin (%) | 20.27 |
Quick Ratio | 3.10 |
Current Ratio | 3.45 |
ROA % (ttm) | 6.03 |
ROE % (ttm) | 7.50 |
ROIC % (ttm) | 9.69 |
Dividend Yield % | 2.02 |
Altman Z-Score | 9.51 |
SZSE:301263 Number of Guru Trades
SZSE:301263 Volume of Guru Trades
Gurus Latest Trades with SZSE:301263
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301263 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangdong Taienkang Pharmaceutical Co Ltd Insider Transactions
No Available Data